Mixed amphetamine salts extended release: Clinical Trials

2 trials of Mixed amphetamine salts extended release, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Not yet recruiting 1

Follow Mixed amphetamine salts extended release: new trials by email Literature Review of Mixed amphetamine salts extended release trials Research Report on Mixed amphetamine salts extended release

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
EEG Biomarkers for ADHD Stimulant Treatment
methylphenidate HCl, Mixed amphetamine salts extended release - ADHD
Phase 4Not yet recruitingBoston Children's Hospital2202026-09-152026-06-16
Comparing the Effectiveness of New Versus Older Treatments for Attention Deficit Hyperactivity Disorder (The NOTA Study)
Methylphenidate transdermal system, Lisdexamfetamine dimesylate, Osmotic-release oral system methylphenidate (OROS MPH) - Attention Deficit Disorder With Hyperactivity
Phase 4CompletedDuke University2282009-04-012013-09-30

Conditions studied

Attention Deficit Disorder with Hyperactivity (2)

Sponsors

Boston Children's Hospital (1)  ·  Duke University (1)

Countries

United States (2)

Top investigators

John S. March, MD, MPH (1)

NIH funding

P30MH066386 (1)